Literature DB >> 9472014

Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

J Zhao1, B Dynlacht, T Imai, T Hori, E Harlow.   

Abstract

To understand the mechanisms by which CDKs regulate cell cycle progression, it is necessary to identify and characterize the physiological substrates of these kinases. We have developed a screening method to identify novel CDK substrates. One of the cDNAs identified in the screen is identical to the recently isolated NPAT gene. Here we show that NPAT associates with cyclin E-CDK2 in vivo and can be phosphorylated by this CDK. The protein level of NPAT peaks at the G1/S boundary. Overexpression of NPAT accelerates S-phase entry, and this effect is enhanced by coexpression of cyclin E-CDK2. These results suggest that NPAT is a substrate of cyclin E-CDK2 and plays a role in S-phase entry.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472014      PMCID: PMC316526          DOI: 10.1101/gad.12.4.456

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  31 in total

1.  Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins.

Authors:  G J Hannon; D Demetrick; D Beach
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

2.  The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E.

Authors:  Y Li; C Graham; S Lacy; A M Duncan; P Whyte
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

3.  Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

Authors:  W Krek; M E Ewen; S Shirodkar; Z Arany; W G Kaelin; D M Livingston
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

4.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

Review 5.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

6.  Cyclin-dependent regulation of G1 in mammalian fibroblasts.

Authors:  M Ohtsubo; J M Roberts
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

7.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

8.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

Authors:  D Resnitzky; M Gossen; H Bujard; S I Reed
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  The cdk2 kinase is required for the G1-to-S transition in mammalian cells.

Authors:  L H Tsai; E Lees; B Faha; E Harlow; K Riabowol
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  72 in total

1.  Differential control of transcription by DNA-bound cyclins.

Authors:  T Y Kim; W G Kaelin
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

2.  African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT.

Authors:  J E Miskin; C C Abrams; L K Dixon
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

Authors:  J Zhao; B K Kennedy; B D Lawrence; D A Barbie; A G Matera; J A Fletcher; E Harlow
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

4.  NPAT expression is regulated by E2F and is essential for cell cycle progression.

Authors:  Guang Gao; Adrian P Bracken; Karina Burkard; Diego Pasini; Marie Classon; Claire Attwooll; Masashi Sagara; Takashi Imai; Kristian Helin; Jiyong Zhao
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 5.  The dynamic organization of gene-regulatory machinery in nuclear microenvironments.

Authors:  Sayyed K Zaidi; Daniel W Young; Je-Yong Choi; Jitesh Pratap; Amjad Javed; Martin Montecino; Janet L Stein; Andre J van Wijnen; Jane B Lian; Gary S Stein
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

6.  Developmental and cell cycle regulation of the Drosophila histone locus body.

Authors:  Anne E White; Michelle E Leslie; Brian R Calvi; William F Marzluff; Robert J Duronio
Journal:  Mol Biol Cell       Date:  2007-04-18       Impact factor: 4.138

7.  Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

Authors:  T Ma; N Zou; B Y Lin; L T Chow; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  Staged assembly of histone gene expression machinery at subnuclear foci in the abbreviated cell cycle of human embryonic stem cells.

Authors:  Prachi N Ghule; Zbigniew Dominski; Xiao-Cui Yang; William F Marzluff; Klaus A Becker; J Wade Harper; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

Review 9.  WEE1 tyrosine kinase, a novel epigenetic modifier.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Trends Genet       Date:  2013-03-26       Impact factor: 11.639

10.  Transcriptional activation of the histone nuclear factor P (HiNF-P) gene by HiNF-P and its cyclin E/CDK2 responsive co-factor p220NPAT defines a novel autoregulatory loop at the G1/S phase transition.

Authors:  Rong-Lin Xie; Lijun Liu; Partha Mitra; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Gene       Date:  2007-08-09       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.